SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-007202
Filing Date
2023-04-28
Accepted
2023-04-28 12:23:50
Documents
21

Document Format Files

Seq Description Document Type Size
1 DEF 14A qure-20230613xdef14a.htm   iXBRL DEF 14A 2025793
2 GRAPHIC qure-20230613xdef14a_a007.jpg GRAPHIC 13982
3 GRAPHIC qure-20230613xdef14a_a009.jpg GRAPHIC 4182
4 GRAPHIC qure-20230613xdef14a_a010.jpg GRAPHIC 5093
5 GRAPHIC qure-20230613xdef14a_a017.jpg GRAPHIC 47140
6 GRAPHIC qure-20230613xdef14a_a018.jpg GRAPHIC 49567
7 GRAPHIC qure-20230613xdef14a_bg001.jpg GRAPHIC 184488
8 GRAPHIC qure-20230613xdef14a_bg002.jpg GRAPHIC 163845
  Complete submission text file 0001558370-23-007202.txt   3966945

Data Files

Seq Description Document Type Size
9 EX-101.SCH qure-20230613.xsd EX-101.SCH 5295
10 EX-101.DEF qure-20230613_def.xml EX-101.DEF 6384
11 EX-101.LAB qure-20230613_lab.xml EX-101.LAB 12459
12 EX-101.PRE qure-20230613_pre.xml EX-101.PRE 6375
15 EXTRACTED XBRL INSTANCE DOCUMENT qure-20230613xdef14a_htm.xml XML 197713
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36294 | Film No.: 23862787
SIC: 2834 Pharmaceutical Preparations